PL2659004T3 - Modulacja dyneiny w skórze - Google Patents

Modulacja dyneiny w skórze

Info

Publication number
PL2659004T3
PL2659004T3 PL11853773T PL11853773T PL2659004T3 PL 2659004 T3 PL2659004 T3 PL 2659004T3 PL 11853773 T PL11853773 T PL 11853773T PL 11853773 T PL11853773 T PL 11853773T PL 2659004 T3 PL2659004 T3 PL 2659004T3
Authority
PL
Poland
Prior art keywords
dynein
modulation
skin
Prior art date
Application number
PL11853773T
Other languages
English (en)
Inventor
Qian Zheng
John W. Lyga
Russell J. Wyborski
Original Assignee
Avon Products, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Avon Products, Inc. filed Critical Avon Products, Inc.
Publication of PL2659004T3 publication Critical patent/PL2659004T3/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/46—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing sulfur
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/46—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing sulfur
    • A61K8/466—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing sulfur containing sulfonic acid derivatives; Salts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/494—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783—Angiosperms [Magnoliophyta]
    • A61K8/9789—Magnoliopsida [dicotyledons]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5082—Supracellular entities, e.g. tissue, organisms
    • G01N33/5088—Supracellular entities, e.g. tissue, organisms of vertebrates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/74—Biological properties of particular ingredients
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/136—Screening for pharmacological compounds
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/148—Screening for cosmetic compounds
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Analytical Chemistry (AREA)
  • Immunology (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physics & Mathematics (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Pathology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Cell Biology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Dermatology (AREA)
  • Medicinal Chemistry (AREA)
  • Mycology (AREA)
  • Food Science & Technology (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Botany (AREA)
  • General Physics & Mathematics (AREA)
  • Toxicology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • General Chemical & Material Sciences (AREA)
PL11853773T 2010-12-30 2011-11-29 Modulacja dyneiny w skórze PL2659004T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201061428272P 2010-12-30 2010-12-30
PCT/US2011/062279 WO2012091832A2 (en) 2010-12-30 2011-11-29 Modulation of dynein in skin
EP11853773.7A EP2659004B1 (en) 2010-12-30 2011-11-29 Modulation of dynein in skin

Publications (1)

Publication Number Publication Date
PL2659004T3 true PL2659004T3 (pl) 2017-12-29

Family

ID=46380940

Family Applications (2)

Application Number Title Priority Date Filing Date
PL15152603T PL2889384T3 (pl) 2010-12-30 2011-11-29 Sposób identyfikowania środków aktywnych do poprawiania wyglądu estetycznego skóry ludzkiej
PL11853773T PL2659004T3 (pl) 2010-12-30 2011-11-29 Modulacja dyneiny w skórze

Family Applications Before (1)

Application Number Title Priority Date Filing Date
PL15152603T PL2889384T3 (pl) 2010-12-30 2011-11-29 Sposób identyfikowania środków aktywnych do poprawiania wyglądu estetycznego skóry ludzkiej

Country Status (11)

Country Link
US (1) US20120171133A1 (pl)
EP (2) EP2659004B1 (pl)
JP (1) JP6249777B2 (pl)
CN (1) CN103561718B (pl)
BR (1) BR112013016935A2 (pl)
CA (1) CA2822328A1 (pl)
ES (1) ES2645011T3 (pl)
MX (1) MX354734B (pl)
PL (2) PL2889384T3 (pl)
TW (1) TWI579002B (pl)
WO (1) WO2012091832A2 (pl)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA3239245A1 (en) * 2009-08-26 2011-03-10 Mary Kay Inc. Topical skin care formulations comprising plant extracts
US8815265B2 (en) 2010-06-30 2014-08-26 Avon Products, Inc. Cosmetic use of N-substituted sulfonyloxybenzylamines and related compounds
EP2588593B1 (en) 2010-06-30 2017-08-23 Avon Products, Inc. Compositions and methods for stimulating magp-1 to improve the appearance of skin
US8455518B2 (en) * 2010-12-28 2013-06-04 Avon Products, Inc. Method of treating skin with microRNA modulators
US8686013B2 (en) * 2011-08-25 2014-04-01 Avon Products, Inc. Cosmetic use of substituted amino heterocylic carbamoyl analogs and related compounds
WO2014158877A1 (en) * 2013-03-13 2014-10-02 Avon Products, Inc Vernonia cinerea extracts and methods of use
KR101821010B1 (ko) * 2014-11-11 2018-01-23 건국대학교 산학협력단 클리나칸투스 누탄스 추출물을 유효성분으로 포함하는 피부 개선용 화장료 조성물
CN106265211B (zh) * 2015-06-03 2020-03-31 上海家化生物科技有限公司 一种肉苁蓉上清混合物、其制备方法及其皮肤屏障修复作用
CN105147571A (zh) * 2015-10-21 2015-12-16 广东药学院 黑面神提取物及其应用和含该黑面神提取物的美白抗皱霜
CN110551828B (zh) * 2019-09-19 2021-02-26 江苏省家禽科学研究所 一种与鸡背部毛孔密度相关的snp分子标记及其应用
CN114957379B (zh) * 2021-06-28 2024-03-26 河南省人民医院 一种二氢嘧啶硫酮类化合物及其制备方法与应用
CN114149985A (zh) * 2021-12-06 2022-03-08 杭州优玛达生物科技有限公司 一种分子马达的制备方法及其应用
CN114478396B (zh) * 2022-03-18 2023-12-01 河南省人民医院 二氢嘧啶(硫)酮类化合物及其制备方法与应用
CN117257670B (zh) * 2023-05-10 2025-07-25 麦吉丽生物科技有限公司 具有去皱抗衰功效的活性分子马达、面霜组合物及制法和应用

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS53136506A (en) * 1977-05-02 1978-11-29 Mototaka Ueno Production of bathing agent being nontoxious to human and animal used in squeezed towell and bath waer to wipe body of0patient * old man and disabled parson
JP3695472B2 (ja) * 1995-03-20 2005-09-14 株式会社コーセー メイラード反応阻害剤
JP2000095663A (ja) * 1998-09-24 2000-04-04 Kose Corp 植物抽出物を含有する外用剤
US6143303A (en) * 1999-08-14 2000-11-07 Janakiram; Chodavarapu Analgesic anti-inflammatory composition and method of preparing from dodonaea sp
US20030032771A1 (en) * 2001-02-14 2003-02-13 Sharp David J. Peptide inhibitors of cellular proliferation
JP2002322076A (ja) * 2001-02-26 2002-11-08 Oji Paper Co Ltd トリプシン阻害剤
CA2439402A1 (en) 2001-03-02 2002-09-12 University Of Pittsburgh Of The Commonwealth System Of Higher Education Pcr method
US20070010657A1 (en) * 2002-09-13 2007-01-11 Rainer Klocke Cytoplasmic dynein heavy chain 1 genes, expression products, non-human animal model uses in human neurological diseases
WO2004026249A2 (en) * 2002-09-20 2004-04-01 The General Hospital Corporation Methods and compositions for preventing skin damage
JP4224387B2 (ja) * 2003-12-04 2009-02-12 日本メナード化粧品株式会社 皮膚外用剤
US20050136028A1 (en) * 2003-12-19 2005-06-23 Dmitri Ptchelintsev Cosmetic compositions having extracts of Amomum melegueta and methods of treating skin
CN102210663B (zh) * 2004-05-28 2013-07-31 尤尼根公司 作为双核酶强效抑制剂的二芳基烷烃
AU2005271961B8 (en) 2004-07-09 2011-11-24 University Of Pittsburgh - Of The Commonwealth System Of Higher Education Identification of markers in esophageal cancer, colon cancer, head and neck cancer and melanoma
JP4777738B2 (ja) * 2004-10-14 2011-09-21 株式会社 資生堂 Ａｄａｍ活性阻害物質によるしわの防止または改善
GB0426255D0 (en) * 2004-11-30 2004-12-29 Younger Skin Ltd Improvements in and relating to products for skin treatment
WO2007094384A1 (ja) * 2006-02-15 2007-08-23 Pola Chemical Industries Inc. フラバノン誘導体を含む皮膚外用剤
CN100475189C (zh) * 2006-10-17 2009-04-08 王海龙 一种化妆品组合物及其制备方法和应用
KR100999261B1 (ko) * 2007-10-09 2010-12-07 (주)아모레퍼시픽 여성호르몬 결핍으로 초래되는 여성 피부의 노화 억제제 스크리닝 방법
JP2009209063A (ja) * 2008-03-03 2009-09-17 Univ Kinki 皮膚外用剤または皮膚化粧料
CN102014930A (zh) * 2008-03-28 2011-04-13 如新国际公司 用于抑制活性氧物质的包含arnox-抑制剂的组合物
CN102137673A (zh) * 2008-04-30 2011-07-27 纽约大学 作为黑素生成调节剂的甾族化合物及其用途
US7592024B1 (en) * 2008-12-29 2009-09-22 Avon Products, Inc. Topical compositions containing melicope hayselii and a method of treating skin
JP5867981B2 (ja) * 2009-06-05 2016-02-24 丸善製薬株式会社 マトリックスメタロプロテアーゼ−１（ｍｍｐ−１）活性阻害剤、エストロゲン様作用剤、ｉ型コラーゲン産生促進剤、ヒアルロン酸産生促進剤、及びｕｖ−ｂダメージからの回復剤
US20110044920A1 (en) * 2009-08-07 2011-02-24 Mary Kay Inc. Topical skin care formulations
CA3239245A1 (en) * 2009-08-26 2011-03-10 Mary Kay Inc. Topical skin care formulations comprising plant extracts
CN106367478A (zh) * 2009-12-22 2017-02-01 雅芳产品公司 桩蛋白刺激组合物及其化妆品用途
WO2012002950A1 (en) * 2010-06-30 2012-01-05 Avon Products, Inc. Use of tiliacora triandra in cosmetics and compositions thereof
EP2588593B1 (en) * 2010-06-30 2017-08-23 Avon Products, Inc. Compositions and methods for stimulating magp-1 to improve the appearance of skin
US8815265B2 (en) * 2010-06-30 2014-08-26 Avon Products, Inc. Cosmetic use of N-substituted sulfonyloxybenzylamines and related compounds
CN101973853B (zh) * 2010-09-29 2013-04-03 桂林莱茵生物科技股份有限公司 羟基酪醇的提取方法

Also Published As

Publication number Publication date
US20120171133A1 (en) 2012-07-05
MX2013007435A (es) 2013-09-06
EP2659004B1 (en) 2017-08-30
JP2014507132A (ja) 2014-03-27
TW201304816A (zh) 2013-02-01
EP2659004A2 (en) 2013-11-06
EP2889384A1 (en) 2015-07-01
WO2012091832A3 (en) 2012-09-07
JP6249777B2 (ja) 2017-12-20
ES2645011T3 (es) 2017-12-01
BR112013016935A2 (pt) 2016-08-30
CN103561718A (zh) 2014-02-05
TWI579002B (zh) 2017-04-21
CN103561718B (zh) 2020-06-16
WO2012091832A2 (en) 2012-07-05
MX354734B (es) 2018-03-16
EP2889384B1 (en) 2016-09-28
PL2889384T3 (pl) 2017-07-31
CA2822328A1 (en) 2012-07-05
EP2659004A4 (en) 2014-05-14

Similar Documents

Publication Publication Date Title
EP2659004A4 (en) MODULATION OF DYNENE IN THE SKIN
PL2652193T3 (pl) Obróbka
PL2542101T3 (pl) Modulacja poposiłkowego wchłaniania tłuszczu
PL2654896T3 (pl) Leczenie owrzodzeń skóry
ZA201208413B (en) Skin treatment composition
GB201002959D0 (en) Tissue expander
EP2659878A4 (en) SKIN CLEANSING COMPOSITION
EP2301522A4 (en) WATER IN OIL EMULSION COSMETIC PREPARATION
EP2521569A4 (en) COMBINATION THERAPY WITH VB-201
PL2482786T3 (pl) Jednorazowy aplikator
GB201004924D0 (en) Medical/cosmetic device
HUE041512T2 (hu) Új kombináció és alkalmazás
PT2563806E (pt) Leucolectinas humanas e suas utilizações
GB201015822D0 (en) Medical ruggedised case
ZA201208568B (en) Skin treatment composition
GB201013573D0 (en) Treatment
GB201010771D0 (en) Forceps
GB2482962B (en) Stretcher
EP2575635A4 (en) Tissue retractor stay
GB201014097D0 (en) Treatment
GB201005342D0 (en) Skin lightening formulation
PH32010000230S1 (en) Tissue
HU1000599D0 (en) Skin care composition
GB201007128D0 (en) Medical applicator
GB201018748D0 (en) KYC secure